The study of cellular aging dates back to 1893 when biologist August Weismann proposed the “wear and tear” theory on cells (1). This laid the foundation for the differentiation between chronological and biological aging concepts, which remain central to contemporary aging research. Chronological aging represents the passage of time and does not necessarily reflect an individual’s health status. By contrast, biological aging reflects the physiological changes influenced by genetic, environmental, and lifestyle factors. Biological age partially explains the variation observed in health outcomes among people of the same chronological age. Therefore, diagnostics of biological age may provide clinical insight into patient care. A human plasma proteomics aging study developed 2 new aging metrics, ProtAge (a biologically driven measure) and ProtAgeGap (the difference between chronological age and ProtAge) to predict risks for age-related diseases (2). These metrics were developed using a machine learning algorithm applied to a plasma proteome dataset from a large UK Biobank cohort (n = 45 441). This model incorporated functional aging phenotypical factors including biomarkers of physical and cognitive function, self-rated health, components of the frailty index, and telomere length, among others. The predictive power of this approach was validated with 2 separate studies (China Kadoorie Biobank n = 3977 and FinnGen n = 1990 cohorts). The findings resulted in observations of consistent proteomic aging profiles between diverse populations.